Ritalin SR en es it fr

Ritalin SR Brand names, Ritalin SR Analogs

Ritalin SR Brand Names Mixture

  • No information avaliable

Ritalin SR Chemical_Formula


Ritalin SR RX_link


Ritalin SR fda sheet

Ritalin_SR FDA

Ritalin SR msds (material safety sheet)

Ritalin_SR MSDS

Ritalin SR Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Ritalin SR Molecular Weight

233.306 g/mol

Ritalin SR Melting Point


Ritalin SR H2O Solubility


Ritalin SR State


Ritalin SR LogP


Ritalin SR Dosage Forms

Tablets; Tablets (sustained release)

Ritalin SR Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Ritalin SR Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Ritalin SR Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Ritalin SR side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Ritalin SR Patient Information

Ritalin SR Organisms Affected

Humans and other mammals